Stay updated on Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision identifier updated from v3.6.4 to v3.6.5. This reflects a newer platform version for the study record history page and does not change the underlying data.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history now shows a new revision entry v3.6.4 replacing v3.6.3, indicating an updated version of the page in ClinicalTrials.gov rather than changes to the study data.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study record history now shows a newer Revision: v3.6.3 replacing the previous Revision: v3.6.2. This reflects a minor administrative update to the page record rather than a substantive change to study data.SummaryDifference0.1%

- Check56 days agoChange DetectedThe History page shows a newer Revision tag (v3.6.2) in the footer, replacing the previous v3.6.0, indicating a recent page or site update rather than changes to the study data.SummaryDifference0.1%

- Check70 days agoChange DetectedThe record history now shows the study is no longer recruiting participants and introduces a new revision label (v3.6.0), while the previous revision (v3.5.5) is removed from the history.SummaryDifference0.4%

- Check77 days agoChange DetectedA new revision entry v3.5.5 was added to the record history. The previous revision v3.5.4 was removed.SummaryDifference0.1%

Stay in the know with updates to Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.